Maintenance therapy after 1st line chemotherapy for advanced urothelial carcinoma, 21 Apr. 2023, 20 Apr. 2023, 23 Apr. 2023, Poster presentation, Japan, False
Multicenter real-word date of maintenance therapy after first-line chemotherapy for advanced urotheline carcinoma:YUSHIMA study, Keita Izumi, Hajime Tanaka, Masataka Yano, Ryoji Takazawa, Akira Noro, Tetsuo Tsukamoto, Yonese Junji, Testuo Okuno, Yasuyuki Sakai, Yukio Kageyama, Fumitaka Koga, Kazutaka Saito, Yasuhisa Fujii., 25 Apr. 2024, Japan
Prognostic impact of bone metastasis in up front androgen receptor-axis-targeted therapy for metastatic castration-sensitinve prostate vancer prostate cancer, Akinori Nakayama, Erika Ilezoe, Minoru Inoue, Hiroki Tsujioka, Asumi nirazuka, ki
Testicular sperm retrieval in hemodialysis patients with sexual dysfunction, Akiyoshi Oosaka, Toshiyuki Iwahata, Erika Ikezoe, Minoru Inoue, Hiroki Tsujioka, Kintaro Hasegawa, Nirazuka Asumi, Miho Sugie, Yuka Yasuda, Keita Izumi, Akinori Nakayama, Hiroshi Okada, Kazutaka Saito., 26 Apr. 2024
Algorithm for neoadjuvant chemotherapy in nonmetastatic upper tract urothelial carcinoma, Asumi Nirazuka, Keita Izumi, Erika Ikezoe, Minoru Inoue, Hiroki Tsujioka, Kinotaro Hasegawa, Akiyoshi Oosaka, Yuka Yasuda, Akinori Nakayama, Kiyoshi Setoguchi, Kazutaka Saito., 25 Apr. 2024
Histologic-based tumor microenvironment characteristics of serum inflamed tumor in clear cell renal cell carcinoma, Minoru Inoue, Keita Izumi, Akinori Nakayama, Chisato Ohe, Shinichi Ban, Kazutaka Saito., 25 Apr. 2024